Clinical trial
Conditioning, the Placebo Effect, and Psoriasis
NCT00005922 · University of Rochester, Other · Completed
Key facts
| NCT number | NCT00005922 |
|---|---|
| Title | Conditioning, the Placebo Effect, and Psoriasis |
| Official title | Role of Conditioning in the Pharmacotherapy of Psoriasis |
| Lead sponsor | University of Rochester, Other |
| Collaborators | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Psoriasis |
| Intervention type | Behavioral, Drug, Other |
| Interventions | Partial schedule of pharmacotherapeutic reinforcement, Dose control for Arm B, Standard pharmacotherapeutic protocol |
| Enrollment | 138 |
| Start date | Aug 1, 2000 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Jun 23, 2000 |
| Last update posted | Sep 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: